文献速递产科

在抑郁筛查基础上增加围产期焦虑筛查是否值得?

Adding perinatal anxiety screening to depression screening: is it worth it?
PubMed 文献 · Am J Obstet Gynecol MFM · 2020-03-13

本研究评估在常规抑郁筛查基础上增加围产期焦虑筛查能否提高需要心理支持女性的识别率。研究在24-28周产前检查时先仅用PHQ-2筛查3个月,随后加用GAD-2。结果显示增加焦虑筛查后,焦虑阳性而抑郁筛查阴性的女性被识别出来,且在有精神健康诊断或物质滥用史亚组中转诊率显著增加。

要点

  • 在抑郁筛查基础上加用GAD-2可识别抑郁筛查阴性的焦虑阳性孕妇。
  • 总体心理转诊率两组无显著差异,但有精神健康诊断或物质滥用史者转诊率显著增加。
  • 围产期焦虑筛查的实施方式仍需进一步研究。

核心结论

  • 围产期焦虑筛查可能增加转诊至精神卫生专业人员的比率,从而诊断和治疗情绪及焦虑障碍。
  • 焦虑筛查可能对有精神健康诊断或物质滥用史的人群特别有用。
  • 需要进一步研究以了解围产期焦虑筛查的最佳实施方式。

研究设计与样本

  • 前瞻性研究,在24-28周产前检查时先仅用PHQ-2筛查3个月(PHQ-2-only组),随后加用GAD-2(PHQ-2+GAD-2组)。
  • PHQ-2-only组有100名女性符合筛查条件,PHQ-2+GAD-2组有125名女性符合筛查条件。

主要发现

  • PHQ-2-only组51名女性接受筛查,2例抑郁筛查阳性。
  • PHQ-2+GAD-2组40名女性接受筛查,5例抑郁筛查阳性,4例焦虑筛查阳性。
  • 3名焦虑阳性女性抑郁筛查为阴性。
  • 两组心理转诊无差异(OR 1.75;95%CI 0.76-4.97)。
  • 有精神健康诊断史亚组转诊显著增加(OR 14.9;95%CI 5.6-39.7),有物质滥用史亚组亦显著增加(OR 26.7;95%CI 4.6-155.0)。

关键数值与推荐

  • 抑郁筛查使用Patient Health Questionnaire-2(PHQ-2),焦虑筛查使用Generalized Anxiety Disorder 2-item(GAD-2)。
  • 主要结局为孕期抑郁和焦虑筛查阳性率;次要结局包括转诊至精神卫生服务的比率及产科和医学结局。

临床怎么用

  • 可考虑在24-28周产前检查时在抑郁筛查基础上增加GAD-2焦虑筛查。
  • 对有精神健康诊断或物质滥用史的孕妇,焦虑筛查可能尤其有助于识别需要转诊者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Screening for peripartum depression is widely recommended and should now be the standard of care. However, little research exists on peripartum anxiety screening. OBJECTIVE: The purpose of this study was to assess whether adding perinatal anxiety screening would increase the identification of women who would benefit from mental health support. STUDY DESIGN: The existing practice at our clinic was depression screening via the Patient Health Questionnaire-2 at all prenatal visits; screenings were prospectively tracked for 3 months in women presenting for visit at 24-28 weeks gestation (Patient Health Questionnaire-2-only group). We then added Generalized Anxiety Disorder 2-item validated anxiety scale assessment to prenatal visits at 24-28 weeks gestation (Patient Health Questionnaire-2+Generalized Anxiety Disorder 2-item group). Our primary study outcome was the rate of positive depression and anxiety screens during pregnancy; secondary outcomes included referral rates to mental health services and obstetric and medical outcomes. RESULTS: A total of 100 women with visits at 24-28 weeks gestation were eligible to be screened during the Patient Health Questionnaire-2-only period; 125 women were eligible for screening during the Patient Health Questionnaire-2+Generalized Anxiety Disorder 2-item period. In the Patient Health Questionnaire-2-only group, 51 women were screened, with 2 positive depression screens. In the Patient Health Questionnaire-2+Generalized Anxiety Disorder 2-item group, 40 women were screened, with 5 positive screens for depression and 4 for anxiety. Three women who were anxiety-positive had been negative via depression screening. Mental health referral was not different between the 2 groups (odds ratio, 1.75; 95% confidence interval, 0.76-4.97), but a significant increase in referral was noted for Patient Health Questionnaire-2+Generalized Anxiety Disorder 2-item subgroups with a history of mental health diagnosis (odds ratio, 14.9; 95% confidence interval, 5.6-39.7) or substance abuse (odds ratio, 26.7; 95% confidence interval, 4.6-155.0). CONCLUSION: Screening for perinatal anxiety may increase referral rates to mental health professionals who can then diagnose and treat women who experience mood and anxiety disorders. Anxiety screening may be particularly useful in populations with a history of mental health diagnoses or substance abuse. Further research is necessary to understand how perinatal anxiety screening should be best implemented.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Lieb K, Reinstein S, Xie X, et al. Adding perinatal anxiety screening to depression screening: is it worth it? Am J Obstet Gynecol MFM. 2020. PMID: 33345965. doi:10.1016/j.ajogmf.2020.100099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。